|
| 36702174 | Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19. | Anaerobe | 2023 |
| 37547012 | PheMIME: An Interactive Web App and Knowledge Base for Phenome-Wide, Multi-Institutional Multimorbidity Analysis. | medRxiv | 2023 |
| 37877021 | Taking AIM at serious illness: implementing an access to investigational medicines expanded access program. | Front Med (Lausanne) | 2023 |
| 37039791 | Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. | JAMA | 2023 |
| 36472455 | Interactive network-based clustering and investigation of multimorbidity association matrices with associationSubgraphs. | Bioinformatics | 2023 |
| 34901783 | Standardized two-step testing of antibody activity in COVID-19 convalescent plasma. | iScience | 2022 |
| 35435937 | Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial. | JAMA Intern Med | 2022 |
| 35574155 | The IRB Reliance Exchange (IREx): A national web-based platform for operationalizing single IRB review. | J Clin Transl Sci | 2022 |
| 35780813 | Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial. | Chest | 2022 |
| 35656334 | Securely sharing DSMB reports to speed decision making from multiple, concurrent, independent studies of similar treatments in COVID-19. | J Clin Transl Sci | 2022 |
| 36755543 | Using a multicultural and multilingual awareness-raising strategy to enhance enrollment of racially underrepresented minoritized communities - the <i>PassITON</i> trial. | J Clin Transl Sci | 2022 |
| 36344144 | Response. | Chest | 2022 |
| 32958289 | The Astounding Breadth of Health Disparity: Phenome-Wide Effects of Race on Disease Risk. | J Natl Med Assoc | 2021 |
| 33743799 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Trials | 2021 |
| 33521603 | A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity. | iScience | 2021 |
| 33635834 | Learning From What We Do, and Doing What We Learn: A Learning Health Care System in Action. | Acad Med | 2021 |
| 33688640 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Res Sq | 2021 |
| 34888064 | The Recruitment Innovation Center: Developing novel, person-centered strategies for clinical trial recruitment and retention. | J Clin Transl Sci | 2021 |
| 34394194 | Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases. | Front Genet | 2021 |
| 33051675 | PheWAS-ME: a web-app for interactive exploration of multimorbidity patterns in PheWAS. | Bioinformatics | 2021 |
| 32732018 | Uncovering Outcome Disparities of β<sub>2</sub> Adrenergic Agonists in Blacks: A Systematic Review. | J Natl Med Assoc | 2021 |
| 31337270 | Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data. | Annu Rev Pharmacol Toxicol | 2020 |
| 33033174 | Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study. | Mol Cancer Ther | 2020 |
| 32112228 | Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. | Drug Saf | 2020 |
| 32269465 | Exploring Biologic Predictors Response Disparities to Atypical Antipsychotics among Blacks: A Quasi-Systematic Review. | Ethn Dis | 2020 |
| 32457445 | EHRs could clarify drug safety in pregnant people. | Nat Med | 2020 |
| 30782860 | A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X during <i>Acinetobacter baumannii</i> Infection. | Infect Immun | 2019 |
| 31660243 | To end disease tomorrow, begin with trials today: Digital strategies for increased awareness of a clinical trials finder. | J Clin Transl Sci | 2019 |
| 31769998 | Systematically Prioritizing Candidates in Genome-Based Drug Repurposing. | Assay Drug Dev Technol | 2019 |
| 31276810 | COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease. | J Pain Symptom Manage | 2019 |
| 31037558 | We're not all cut from the same cloth: TAILORing treatments for children with chronic conditions. | J Patient Rep Outcomes | 2019 |
| 30830824 | Understanding What Information Is Valued By Research Participants, And Why. | Health Aff (Millwood) | 2019 |
| 29016793 | Mining 100 million notes to find homelessness and adverse childhood experiences: 2 case studies of rare and severe social determinants of health in electronic health records. | J Am Med Inform Assoc | 2018 |
| 30066313 | Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors". | Drug Saf | 2018 |
| 31011433 | A collaborative, academic approach to optimizing the national clinical research infrastructure: The first year of the Trial Innovation Network. | J Clin Transl Sci | 2018 |
| 30820361 | Connecting the public with clinical trial options: The ResearchMatch Trials Today tool. | J Clin Transl Sci | 2018 |
| 30637122 | The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTA. | J Reprod Biotechnol Fertil | 2018 |
| 29448118 | Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications. | Pharmacol Res | 2018 |
| 29726581 | PregOMICS-Leveraging systems biology and bioinformatics for drug repurposing in maternal-child health. | Am J Reprod Immunol | 2018 |
| 29788759 | Advocating for mutually beneficial access to shelved compounds. | Future Med Chem | 2018 |
| 29185237 | Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors. | Drug Saf | 2018 |
| 29218624 | Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program. | Target Oncol | 2018 |
| 27561086 | Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results. | Genet Med | 2017 |
| 28379727 | Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. | Assay Drug Dev Technol | 2017 |
| 28090649 | The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. | Clin Pharmacol Ther | 2017 |
| 29193979 | When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data. | Assay Drug Dev Technol | 2017 |
| 28823925 | Recruitment methods for survey research: Findings from the Mid-South Clinical Data Research Network. | Contemp Clin Trials | 2017 |
| 26693963 | Physician response to implementation of genotype-tailored antiplatelet therapy. | Clin Pharmacol Ther | 2016 |
| 26628336 | A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program. | J Clin Epidemiol | 2016 |
| 26261062 | Attitudes of clinicians following large-scale pharmacogenomics implementation. | Pharmacogenomics J | 2016 |